BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 10188934)

  • 21. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
    Okada F; Horikawa T; Tokumitsu Y; Nomura Y
    Neurochem Int; 1994 Jan; 24(1):23-7. PubMed ID: 8130732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
    Lee D; Huang W; Lim AT
    Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward.
    Ikemoto S; Glazier BS; Murphy JM; McBride WJ
    J Neurosci; 1997 Nov; 17(21):8580-7. PubMed ID: 9334429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic modulation of mitral cell activity in the frog olfactory bulb: a combined radioligand binding-electrophysiological study.
    Duchamp-Viret P; Coronas V; Delaleu JC; Moyse E; Duchamp A
    Neuroscience; 1997 Jul; 79(1):203-16. PubMed ID: 9178876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of G protein betagamma subunits in muscarinic receptor-induced stimulation and inhibition of adenylyl cyclase activity in rat olfactory bulb.
    Olianas MC; Ingianni A; Onali P
    J Neurochem; 1998 Jun; 70(6):2620-7. PubMed ID: 9603229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABA(B) receptor-mediated stimulation of adenylyl cyclase activity in membranes of rat olfactory bulb.
    Olianas MC; Onali P
    Br J Pharmacol; 1999 Feb; 126(3):657-64. PubMed ID: 10188976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
    Gáborján A; Lendvai B; Vizi ES
    Neuroscience; 1999 Apr; 90(1):131-8. PubMed ID: 10188940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
    Wang HY; Undie AS; Friedman E
    Mol Pharmacol; 1995 Dec; 48(6):988-94. PubMed ID: 8848015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
    Zhao Y; Kerscher N; Eysel U; Funke K
    J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.